Medizinische Hochschule Hannover (MHH) / Hannover Medical School

University / College


Location: Hannover, Germany (DE) DE

ISNI: 0000000095299877

ROR: https://ror.org/00f2yqf98

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Pulmonary Dysfunction after Pediatric COVID-19 (2022) Heiß R, Tan L, Schmidt S, Regensburger A, Ewert F, Mammadova D, Bühler A, et al. Journal article Anaplastic ganglioglioma-A diagnosis comprising several distinct tumour types (2022) Reinhardt A, Pfister K, Schrimpf D, Stichel D, Sahm F, Reuss DE, Capper D, et al. Journal article Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL - long-term follow-up from the prospective ALL-SCT 2003 trial (2022) Eichinger A, Poetschger U, Glogova E, Bader P, Basu O, Beier R, Burkhardt B, et al. Journal article A novel orthotopic TCR transgenic mouse model dissects the role of antigen receptor specificity for gamma delta T cell development and function (2022) Vogg L, Hahn AM, Schäfer S, Ravens S, Prinz I, Winkler T Conference contribution Sialic acids on B cells are crucial for their survival and provide protection against apoptosis (2022) Linder A, Schmidt M, Hitschfel J, Schneider P, Abeln M, Gerardy-Schahn R, Muenster-Kuehnel A, Nitschke L Conference contribution Endothelial dysfunction determines severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks (2022) Ruhl L, Pink I, Kuehne JF, Beushausen K, Keil J, Christoph S, Sauer A, et al. Conference contribution When to treat the pelvis in node-positive vulvar cancer: Results from the AGO-VOP.2 QS vulva study (2022) Hampl M, Jaeger A, Eulenburg C, Prieske K, Hambrecht J, Fuerst S, Klapdor R, et al. Conference contribution BNT211-01: A phase I trial to evaluate safety and efficacy of CLDN6 CAR T cells and CLDN6-encoding mRNA vaccine-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumours (2022) Mackensen A, Haanen JBAG, Koenecke C, Alsdorf W, Wagner-Drouet E, Heudobler D, Borchmann P, et al. Conference contribution Incorporating progesterone receptor expression into the PREDICT breast prognostic model (2022) Grootes I, Keeman R, Blows FM, Milne RL, Giles GG, Swerdlow AJ, Fasching PA, et al. Journal article A randomized phase II trial of ipilimumab and nivolumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNNIFORECAST) (2022) Ahrens M, Escudier B, Haanen J, Gross-Goupil M, Boleti E, Gravis G, Grimm MO, et al. Conference contribution